Effects of metformin on fertilisation of bovine oocytes and early embryo development: Possible involvement of AMPK3-mediated TSC2 activation

Zygote

Volumn 23, Issue 1, 2014, Pages 58-67

  Pikiou, Olympia ^a   Vasilaki, Anna ^a   Leondaritis, George ^a,b   Vamvakopoulos, Nikos ^a   Messinis, Ioannis E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cleavage rate; Early embryos; In vitro culture; Metformin; TSC2

Indexed keywords

BOVINAE;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; TUBERIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; BOVINE; DOSE RESPONSE; DRUG EFFECTS; EMBRYO CULTURE; FEMALE; FERTILIZATION IN VITRO; IN VITRO OOCYTE MATURATION; MALE; METABOLISM; OOCYTE; OOCYTE CLEAVAGE; PHYSIOLOGY; PROCEDURES; ZYGOTE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CATTLE; CLEAVAGE STAGE, OVUM; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO CULTURE TECHNIQUES; FEMALE; FERTILIZATION IN VITRO; IN VITRO OOCYTE MATURATION TECHNIQUES; MALE; METFORMIN; OOCYTES; TUMOR SUPPRESSOR PROTEINS; ZYGOTE;

EID: 84921478544     PISSN: 09671994     EISSN: 14698730     Source Type: Journal    
DOI: 10.1017/S0967199413000300     Document Type: Article

References (48)

1. Adamiak, S.J., Powell, K., Rooke, J.A., Webb, R. & Sinclair, K.D. (2006). Body composition, dietary carbohydrates and fatty acids determine post-fertilisation development of bovine oocytes in vitro. Reproduction 131, 247-58.
2. Adhikari, D., Flohr, G., Gorre, N., Shen, Y., Yang, H., Lundin, E., Lan, Z., Gambello, M.J. & Liu, K. (2009). Disruption of Tsc2 in oocytes leads to overactivation of the entire pool of primordial follicles. Mol. Hum. Reprod. 15, 765-70.
3. Bai, X. & Jiang, Y. (2010). Key factors in mTOR regulation. Cell. Mol. Life Sci. 67, 239-402.
4. Bailey, C.J. (1997).Metformin and its role in the management of type II diabetes. Curr. Opin. Endocrinol. Diabetes 4, 40-7.
5. Bilodeau-Goeseels, S., Sasseville, M., Guillemette, C. & Richard, F.J. (2007). Effects of adenosine monophosphateactivated kinase activators on bovine oocyte nuclear maturation in vitro. Mol. Reprod. Dev. 74, 1021-34.
6. Corradetti, M.N., Inoki, K., Bardeesy, N., DePinho, R.A. & Guan, K.L. (2004). Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev. 18, 1533-8.
7. Downs, S.M., Hudson, E.R. & Hardie, D.G. (2002). A potential role for AMP-activated protein kinase in meiotic induction in mouse oocytes. Dev. Biol. 245, 200-12.
8. Eng, G.S., Sheridan, R.A., Wyman, A., Chi, M.M.Y., Bibee, K.P., Jungheim, E.S. & Moley, K.H. (2007). AMP kinase activation increases glucose uptake, decreases apoptosis and improves pregnancy outcome in embryos exposed to high IGF-I concentrations. Diabetes 56, 2228-34.
9. Gao, X. & Pan, D. (2001). TSC1 and TSC2 tumor suppressors antagonize insulin signalling in cell growth. Genes Dev. 15, 1383-92.
10. Goossens, K., Vandaele, L.,Wydooghe, E., Thys, M., Dewulf, J., Peelman, L.J. & Van Soom, A. (2011). The importance of adequate fixation for immunofluorescent staining of bovine embryos. Reprod. Domest. Anim. 46, 1098-103.
11. Guertin, D.A. & Sabatini, D.M. (2007). Defining the role of mTOR in cancer. Cancer Cell 12, 9-22.
12. Gwinn, DM., Shackelford, D.B., Egan, D.F., Mihaylova, MM., Mery, A., Vasquez, D.S., Turk, B.E. & Shaw, R.J. (2008). AMPK phosphorylation of Raptor mediates a metabolic checkpoint. Cell 30, 214-26.
13. Hardie, D.G. & Carling, D. (1997). The AMP-activated protein kinase: fuel gauge of the mammalian cell? Eur. J. Biochem. 246, 259-73.
14. Hatziefthimiou, A., Kiritsi, M., Kiropoulou, C., Vasilaki, A., Sakellaridis, N. & Molyvdas, P.A. (2009). Regional differences in the modulatory role of the epithelium in sheep airway. Clin. Exp. Pharmacol. Physiol. 36, 668-74.
15. Hazeleger, N.L., Hill, DJ., Stubbings, R.B. & Walton, J.S. (1995). Relationship of morphology and follicular fluid environment of bovine oocytes to their developmental potential in vitro. Theriogenology 43, 509-22.
16. Hong, S.G., Jang, G., Oh, H.J., Koo, O.J., Park, J.E., Park, H.J., Kang, S.K. & Lee, B.C. (2009). The effects of brainderived neurotrophic factor and metformin on in vitro developmental competence of bovine oocytes. Zygote 17, 187-93.
17. Hundal, R.S. & Inzucchi, S.E. (2003). Metformin: new understandings, new uses. Drugs 63, 1879-94.
18. Inoki, K., Zhu, T. & Guan, K. (2003). TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-90.
19. Ito, N. & Rubin, G.M. (1999). Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 96, 529-39.
20. Karttunen, P., Uusitupa, M. & Lamminsivu, U. (1983). The pharmacokinetics of metformin: a comparison of the properties of a rapid-release and a sustained release preparation. Int. J. Clin. Pharmacol. 21, 31-6.
21. Kwong, W.Y., Adamiak, SJ., Gwynn, A., Singh, R. & Sinclair, K.D. (2010). Endogenous folates and singlecarbon metabolism in the ovarian follicle, oocyte and pre implantation embryo. Reproduction 139, 1-12.
22. Leverve, X.M., Guigas, B., Detaille, D., Batandier, C., Koceir, EA., Chauvin, C., Fontaine, E. &Wiernsperger, N.F. (2003). Mitochondrial metabolism and type 2 diabetes: a specific target for metformin. Diabetes Metab. 29, 6588-94.
23. Lord, J.M., Flight, I.H.K. & Norman, R.J. (2003).Metformin in polycystic ovary syndrome: systematic review and metaanalysis. BMJ 327, 951-5.
24. Luo, Z., Zang, M. & Guo, W. (2010). AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol. 6, 457-70.
25. Manning, B.D. & Cantley, L.C. (2003). Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28, 573-6.
26. Matthaei, S., Hamann, A., Klein, H.H., Benecke, H., Kreymann, G., Flier, JS. & Greten, H. (1991). Association of metformin's effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes. Diabetes 40, 850-7.
27. Mayes, M.A., Laforest,M.F., Guillemette, C., Gilchrist, R.B. & Richard, F.J. (2007). Adenosine 5' monophosphate kinaseactivated protein kinase (PRKA). activators delay meiotic resumption in porcine oocytes. Biol. Reprod. 76, 589-97.
28. Meric-Bernstam, F. & Gonzalez-Angulo, A. (2009). Targeting the mTOR signaling network for cancer therapy. J. Clin. Oncol. 27, 2278-87.
29. Musi, N., Hirshman, M.F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J.M., Ljunqvist, O., Efendic, S., Moller, D.E., Thorell, A. & Goodyear, L.J. (2002).Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51, 2074-81.
30. Nardo, L.G. & Rai, R. (2001). Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects. Gynecol. Endocrinol. 15, 373-80.
31. Potter, C.J. & Xu, T. (2001). Mechanisms of size control. Curr Opin Genet Dev 11, 279-477.
32. Sabatini, D.M. (2006). mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 6, 729-34.
33. Sancak, Y., Thoreen, C.C., Peterson, T.R., Lindquist, R.A., Kang, S.A., Spooner, E., Carr, S.A. & Sabatini, D.M. (2007). PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25, 903-15.
34. Sancak, Y., Peterson, T.R., Shaul, Y.D., Lindquist, R.A., Thoreen, C.C., Bar-Peled, L. & Sabatini, D.M. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-501.
35. Shackelford, D.B. & Shaw, R.J. (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer 9, 563-75.
36. Shaw, R.J., Bardeesy, N., Manning, B.D., Lopez, L., Kosmatka, M., DePinho, R.A. & Cantley, L.C. (2004). The LKB1 tumor suppressor negatively regulates mTOR signalling. Cancer Cell 6, 91-9.
37. Shaw, R.J., Lamia, K.A., Vasquez, D., Koo, S.H., Bardeesy, N., DePinho, R.A., Montminy, M. & Cantley, L.C. (2005). The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-6.
38. Stapleton, D., Mitchelhill, KI., Gao, G., Widmer, J., Michell, B.J., Teh, T., House, C.M., Fernandez, S., Cox, T., Witters, L.A. & Kemp, B.E. (1996). Mammalian AMPactivated protein kinase subfamily. J. Biol. Chem. 271, 611-4.
39. Stojkovic, M., Machado, SA., Stojkovic, P., Zakhartchenko, V., Hutzler, P., Goncalves, P.B. & Eckhard, W. (2001). Mitochondrial distribution and adenosine triphosphate content of bovine oocytes before and after in vitro maturation: correlation with morphological criteria and developmental capacity after in vitro fertilization and culture. Biol. Reprod. 64, 904-9.
40. Tapon, N., Ito, N., Dickson, B.J., Treisman, J.E. & Hariharan, I.K. (2001). The Drosophila tuberous sclerosis gene homologs restrict cell growth and cell proliferation. Cell 105, 345-55.
41. Tosca, L., Froment, P., Solnais, P., Ferre, P., Foufelle, F. & Dupont, J. (2005). Adenosine 5' monophosphate-activated protein kinase regulates progesterone secretion in rat granulosa cells. Endocrinology 146, 4500-13.
42. Tosca, L., Solnais, P., Ferre, P., Foufelle, F. & Dupont, J. (2006a). Metformin-induced stimulation of adenosine 5-monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells. Biol. Reprod. 75, 342-51.
43. Tosca, L., Crochet, S., Ferre, P., Foufelle, F., Tesseraud, S. & Dupont, J. (2006b). AMP activated protein kinase activation modulates progesterone secretion in granulosa cells from hen preovulatory follicles. J. Endocrinol. 190, 85-97
44. Tosca, L., Uzbekova, S., Chabrolle, C. & Dupont, J. (2007). Possible role of 5-AMP activated protein kinase in the metformin-mediated arrest of bovine oocytes at the germinal vesicle stage during in vitro maturation. Biol. Reprod. 77, 452-65.
45. Towler, M.C. & Hardie, D.G. (2007). AMP-activated protein kinase in metabolic control and insulin signalling. Circ. Res. 100, 328-41.
46. Vasilaki, A., Papadaki, T., Notas, G., Kolios, G., Mastrodimou, N., Hoyer, D., Tsilimbaris, M., Kouroumalis, E., Pallikaris, I. & Thermos, K. (2004). Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell cultures. Invest. Ophthalmol. Vis. Sci. 45, 1499-506.
47. Wullschleger, S., Loewith, R. & Hall, M.N. (2006). TOR signalling in growth and metabolism. Cell 124, 471-84.
48. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M.F., Goodyear, L.J. & Moller, D.E. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-74.